 Post-operative Autologous Blood Transfusion System |
| |
|
|
Benefits of Using Celltrans™
- Complete Set
All components in a transit bag providing everything required for an Autologous Blood Transfusion and prevents loss of components during transfer to ward.
- Continuous Low Vacuum
In accordance with aaBB guidelines this system operates below 100mmHg and provides a vacuum during its operation. Reduces the need for constant monitoring and reduces the risk of haematoma and haemolysis.
- Easy to Use
Product is easy and simple to use.
- Wound Drainage
Once both transfusion bags have been used, the device may be used as a conventional low vacuum wound drainage device.
- Closed System
Reduces the risk of patient infection from airborne bacteria.
- Latex Free
Prevents any potential latex allergy.
- Non Pyrogenic
Monitored for bacterial endotoxin levels by the LAL Test.
- Cost Effective
Can provide up to 1200ml of blood per patient.
- Training
Tailored to meet the needs of customers.
- Fat Filter
Reduces Leucocytes, Fat Globules, C3a and Microaggregates |
|
|
| |
CellTrans™ product features
1. Two Transfusion Bags -
allows collection of up to 1200ml of transfusable blood or for up to a maximum of 12 hours*
2. Non Return Valves -
prevent back flow of exudate
3. Safety Caps on Bags and Bellows -
prevent accidental blood contamination
4. Easy Repriming -
just squeeze the bellows to maximise vacuum level
5. Clear ‘Y’ Connector -
allows you to insert 2 drains safely
6. Polyurethane Drains -
much stronger than traditional PVC and less painful for the patient when removed
7. Patient Data Recording -
a tag on the bellows and space allocated on the transfusion bags allows patient details, times and dates of operation to be recorded
8. Injection Port -
used for adding anti-coagulants and for taking samples if required
9. Infection Control -
closed unit, to minimise risk of infection
10. Transfusion Bag Patient Data Recording -
adhesive labels provided to enable clear bag identification and for the patient’s records
11. Fat Filter -
reduces Leucocytes, Fat Globules, C3a and Microaggregates |
| |
|
|
| *Timings in accordance with AABB guidelines (American Association of Blood Banks) |
| |
|
|
Independant Scientific Evaluation of CellTrans™
The CellTrans™ ABT system has been independently evaluated in accordance with the ISO10993 standard for haemo-compatibility of medical devices.
De-fibrinated blood was incubated in the device and collected afterwards. The results were compared to simulated knee blood and blood obtained from the blood bank.
The results indicate that the incubation of blood in the CellTrans™ device had no major effects on the measured blood parameters:
- No loss of cells (RBCs, WBCs and Platelets) or haemolysis occurred Figure 1
- No effect on the Haematocrit or level of Haemoglobin Figure 2
- No activation of the clotting cascade and no complement activation was found.
- The level of Plasma Free Haemoglobin was approx 1/4 of that found in banked blood Figure 3
|
|
| click on an image for a larger version |
 |
 |
 | |
| |
|
|
| The Pall LipiGuard® Filter |
|
|
The Pall LipiGuard® Filter has been designed for use with post-operative salvaged blood. It:
- Decreases fat globules present in salvaged blood
- Reduces the burden of leucocytes in salvaged blood
- Lowers concentrations of the anaphylatoxin, C3a and its immunosuppressive metabolite (C3a des Arg77).
- Has a positive effect on the quality of blood due to the inclusion of a 40µm screen. Figure 4
|
|
|
| Pall and Lipiguard are trademarks of Pall Corporation. ® indicates the trademark is registered in the USA. |
| |
|
|
All CellTrans™ components come complete in a double wrapped pack, making ordering simple and straightforward. Simply specify the required trocar size.
The inclusion of 2 trocars and drains means quicker and easier insertion of drains into the wound site. It also eliminates the potential hazards associated with handling sharp instruments.
With the inclusion of 2 transfusion bags it is possible to collect up to 1200ml of transfusable blood or for up to 12 hours*.
The Pall LipiGuard® filter gives the added reassurance that the blood that is re-infused to the patient has significant reductions in fat globules, leucocytes, anaphylatoxin, C3a and its immunosuppressive metabolite (C3a des Arg77).
|
| *Timings in accordance with aaBB guidelines (American Association of Blood Banks) |
| |
|
|
UK and Export
For further information and details of availability of these products by country please contact:
info@summit-medical.co.uk |
| |
|
|
|
Simple, Safe, Effective |
|
|
